In early February, Senator Amy Klobuchar, new Chair of the Senate Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights, introduced the “Competition and Antitrust Law Enforcement Reform Act of...more
The U.S. House of Representatives passed H.R. 1418, the “Competitive Health Insurance Reform Act,” by a voice vote on September 21. The legislation, which was introduced back in early 2019 by Congressman Peter DeFazio...more
As healthcare providers around the country struggle to respond to patient needs during the Covid-19 crisis, many are reportedly struggling financially as well. In the past, this scenario has led to an increase in merger and...more
A bill recently introduced in the Florida legislature (HB 1243) requires Florida hospitals and group physician practices contemplating mergers or acquisitions to provide advance notice of such transactions to the Florida...more
3/22/2019
/ Acquisition Agreements ,
Antitrust Provisions ,
Competition ,
Corporate Sales Transactions ,
Florida ,
Hart-Scott-Rodino Act ,
Health Care Providers ,
Legislative Agendas ,
Merger Agreements ,
Notice Requirements ,
Proposed Legislation ,
State and Local Government
In December, the U.S. Department of Health and Human Services issued a report – “Reforming America’s Healthcare System Through Choice and Competition” – expressly calling upon the states to repeal their “Certificate of Need”...more
2/14/2019
/ Ambulatory Surgery Centers ,
Assisted Living Facilities (ALFs) ,
Certificate of Need ,
Dedicated Emergency Departments ,
Federal Funding ,
Health Care Providers ,
Healthcare Facilities ,
Healthcare Reform ,
Hospitals ,
Inpatient Rehab Facilities ,
Legislative Agendas ,
Long Term Care Facilities ,
Proposed Legislation ,
Regulatory Agenda ,
Reviewability Determinations
Two pieces of related legislation that would prohibit so called “gag clauses” in contracts between pharmacists and health plans and pharmacy benefit managers (PBM’s) have been passed by both the Senate and the House....more
10/9/2018
/ Contract Terms ,
Disclosure ,
Drug Pricing ,
Health Insurance ,
Legislative Agendas ,
Medicare Advantage ,
Medicare Part D ,
Out-of-Pocket Expenses ,
Pending Legislation ,
Pharmaceutical Industry ,
Pharmacies ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Trump Administration